Adam Spaulding
About Adam Spaulding
Adam Spaulding is a Corporate Associate at Gunderson Dettmer, specializing in legal and business matters for early-stage companies. He holds a Bachelor of Arts in History and Political Science from the University of California, Berkeley, and a Doctor of Law from Columbia Law School.
Work at Gunderson Dettmer
Adam Spaulding has been serving as a Corporate Associate at Gunderson Dettmer since 2021. His role focuses on providing legal support to early-stage companies, particularly in the venture capital sector. He utilizes his expertise to guide startups through critical phases of their development, including seed funding and initial public offerings (IPOs). Spaulding's strategic approach aids clients in navigating complex transactions and regulatory landscapes.
Education and Expertise
Adam Spaulding holds a Doctor of Law (J.D.) degree from Columbia Law School, which he completed from 2014 to 2017. Prior to that, he earned a Bachelor of Arts (B.A.) in History and Political Science from the University of California, Berkeley, from 2010 to 2014. His educational background provides a solid foundation for his legal practice, particularly in understanding the regulatory environment for startups.
Background
Before joining Gunderson Dettmer, Adam Spaulding gained diverse legal experience through various internships and clerkships. He worked as a Legal Intern for the United States Air Force in 2010 and 2011, and served as a Law Clerk at the San Francisco District Attorney's Office in 2015. Additionally, he was a Summer Associate at Vinson & Elkins in 2016 and worked as an Associate at Simpson Thacher & Bartlett LLP from 2017 to 2021.
Achievements
Adam Spaulding is recognized for his ability to drive value for clients by advising on legal and business matters related to company formation, financing, and growth. He is passionate about supporting innovative startups in the venture capital space and has successfully guided them through crucial stages of development, including navigating the complexities of funding and IPO processes.